| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/08/2010 | WO2010077976A2 Prokineticin receptor antagonists and uses thereof |
| 07/08/2010 | WO2010077854A1 High affinity human antibodies to pcsk9 |
| 07/08/2010 | WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | WO2010077635A2 Heat moisture treated carbohydrates and uses thereof |
| 07/08/2010 | WO2010077137A1 Protein particles and their use in food |
| 07/08/2010 | WO2010077074A2 Preparation for the treatment of diabetes comprising arginine thiazolidine carboxylate or a derivative thereof |
| 07/08/2010 | WO2010076884A1 Novel fused ring compound and use thereof |
| 07/08/2010 | WO2010076813A1 Thienopyridines as pharmacologically active agents |
| 07/08/2010 | WO2010075824A1 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes |
| 07/08/2010 | WO2010056527A3 B-biphenyl sulfonamide compounds as ion channel modulators |
| 07/08/2010 | WO2010054469A9 Appetite suppressing weight management composition comprising caralluma fimbriata, hoodia gordonii and cissus quadrangularis extracts |
| 07/08/2010 | WO2010052144A3 Neuropeptide-2-receptor (y-2r) agonists and uses thereof |
| 07/08/2010 | WO2010045621A9 Methods and compositions using irvingia gabonensis to reduce weight, control obesity, effect adipogenesis, lower ppar-gamma, leptin, g3pdh and triglyc-erides levels and increase adiponectin levels |
| 07/08/2010 | WO2010036876A3 Compositions and methods for characterizing and restoring gastrointestinal, skin, and nasal microbiota |
| 07/08/2010 | WO2010010531A9 Composition for controlling increase in blood glucose |
| 07/08/2010 | WO2010009139A3 Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors |
| 07/08/2010 | US20100174076 Coumarin derivatives useful as tnf alpha inhibitors |
| 07/08/2010 | US20100173994 Synthesis of triethylenetetramines |
| 07/08/2010 | US20100173984 Epigallocatechin-3-gallate crystal compositions |
| 07/08/2010 | US20100173964 Pharmaceutical composition that includes a dipeptidyl peptidase-iv inhibitor |
| 07/08/2010 | US20100173961 Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors |
| 07/08/2010 | US20100173958 Compounds for the inhibition of dgat1 activity |
| 07/08/2010 | US20100173955 4-substituted phenoxyphenylacetic acid derivatives |
| 07/08/2010 | US20100173951 Novel methods |
| 07/08/2010 | US20100173936 Compositions comprising renin-angiotensin aldosterone system inhibitors and lipoic acid compounds, and the use thereof for the treatment of renin-angiotensin aldosterone system-related disorders |
| 07/08/2010 | US20100173931 Harmine derivatives for reducing body weight |
| 07/08/2010 | US20100173930 Certain Chemical Entities, Compositions and Methods |
| 07/08/2010 | US20100173925 Oxyindole derivatives |
| 07/08/2010 | US20100173916 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
| 07/08/2010 | US20100173905 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome |
| 07/08/2010 | US20100173904 Topical composition, topical composition precursor, and methods for manufacturing and using |
| 07/08/2010 | US20100173896 Organic Compounds |
| 07/08/2010 | US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 07/08/2010 | US20100173894 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 07/08/2010 | US20100173892 Enantioselective synthesis of 6-amino-7-hydroxy-4,5,6,7-tetrahydro-imidazo[4,5,1-JK][1]-benzazepin-2[1H]-one and zilpaterol |
| 07/08/2010 | US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 07/08/2010 | US20100173889 Substituted Pyrimidine and Triazine Compounds |
| 07/08/2010 | US20100173886 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
| 07/08/2010 | US20100173870 Phosphonate Compounds |
| 07/08/2010 | US20100173860 Purifications of Pomegranate Ellagitannins and Their Uses Thereof |
| 07/08/2010 | US20100173848 Methods of inhibiting chemokine binding to chemokines receptors |
| 07/08/2010 | US20100173844 Stable Formulations of Peptides |
| 07/08/2010 | US20100173835 Peptides for Treatment of Obesity |
| 07/08/2010 | US20100173834 Cyclic peptide melanocortin receptor ligands |
| 07/08/2010 | US20100173829 Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof |
| 07/08/2010 | US20100173825 Heteroaryl benzamide derivatives |
| 07/08/2010 | US20100173025 Fat absorption inhibitory composition |
| 07/08/2010 | US20100173022 Composition for the treatment of diabetes mellitus and metabolic syndrome |
| 07/08/2010 | US20100173015 Compositions and methods for the absorption, chelation, and elimination of trace elements |
| 07/08/2010 | US20100173014 Methods of making and using nano scale particles |
| 07/08/2010 | US20100173008 Method of treating or alleviating the symptoms of alesion in mammal |
| 07/08/2010 | US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof |
| 07/08/2010 | US20100172992 Pathogenic attenuation via the administration of an equilibiotic compound |
| 07/08/2010 | US20100172991 Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
| 07/08/2010 | US20100172971 Compositions for Inhibiting NADPH Oxidase Activity |
| 07/08/2010 | US20100172950 Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 kda and processes for their preparation |
| 07/08/2010 | US20100172942 Multi-membrane immunoisolation system for cellular transplant |
| 07/08/2010 | US20100172920 Method of inducing immune tolerance to type i diabetes |
| 07/08/2010 | US20100172916 Substituted hydroxyphenylamine compounds |
| 07/08/2010 | US20100172914 Methods and materials related to trail isoforms |
| 07/08/2010 | US20100172905 Antagonists of hmg1 for treating inflammatory conditions |
| 07/08/2010 | US20100172892 Hyaluronidase and method of use thereof |
| 07/08/2010 | US20100172887 Carbohydrate modifying agent and drinks containing the modifying agent |
| 07/08/2010 | US20100172875 Oil-in-water emulsion and its use for the delayed release of active elements |
| 07/08/2010 | US20100172874 Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity related disorder |
| 07/08/2010 | CA2750137A1 Compositions and methods for treating and preventing weight-related disorders in companion animals |
| 07/08/2010 | CA2748982A1 Thienopyridines as pharmacologically active agents |
| 07/08/2010 | CA2748493A1 Use of apl-type peptide for treating intestinal inflammatory diseases and type 1 diabetes |
| 07/08/2010 | CA2748490A1 Substituted diketopiperazine analogs for use as drug delivery agents |
| 07/08/2010 | CA2747123A1 High affinity human antibodies to pcsk9 |
| 07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | CA2746139A1 Companion animal compositions including lipoic acid and methods of use thereof |
| 07/07/2010 | EP2204368A1 4-sulfonylpiperidine derivatives |
| 07/07/2010 | EP2204360A1 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | EP2204178A1 Laxative agent |
| 07/07/2010 | EP2204173A1 Antidiabetic pharmaceutical composition |
| 07/07/2010 | EP2204169A1 Granular preparation containing biguanide compound |
| 07/07/2010 | EP2203559A2 Combination treatment for the treatment of hepatitis c virus infection |
| 07/07/2010 | EP2203448A1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical |
| 07/07/2010 | EP2203169A1 Glycemic control, diabetes treatment, and other treatments with acetyl cholinesterase inhibitors |
| 07/07/2010 | EP2203061A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 07/07/2010 | EP2029529B1 Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/07/2010 | EP1873153B1 3-azetidinecarboxylic acid derivatives for use as immunosuppressants |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | EP1455601B1 Composition for promotion of bone growth and maintenance of bone health |
| 07/07/2010 | CN1942469B Condensed pyridine derivatives useful as A28 adenosine receptor antagonists |
| 07/07/2010 | CN1784221B Compositions for affecting weight loss |
| 07/07/2010 | CN101772504A substituted bicyclolactam compounds |
| 07/07/2010 | CN101772499A Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 07/07/2010 | CN101772497A New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl] ih- indole- 5 -carbonitrile citrate |
| 07/07/2010 | CN101772494A 4-pyrimidinesulfamide derivative |
| 07/07/2010 | CN101772487A Novel compounds |
| 07/07/2010 | CN101768600A Reg III/proinsulin double-gene plasmid as well as building method and application thereof |
| 07/07/2010 | CN101768202A Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof |
| 07/07/2010 | CN101768145A Nitric oxide-donating chrysin derivatives, preparation method thereof, medical use thereof |
| 07/07/2010 | CN101768133A Diphenylethlene derivative and use thereof |
| 07/07/2010 | CN101768132A Biphenyl compound and preparation method and purposes thereof |
| 07/07/2010 | CN101768097A Method for preparing selenic acid arginine and application of selenic acid arginine |
| 07/07/2010 | CN101768081A Inhibitor of fatty acid synthase and application thereof |